Author:

• Michael Ruberson Ribeiro da Silva - Ribeiro da Silva, Michael Ruberson - Belo Horizonte, Minas Gerais - Universidade Federal de Minas Gerais, Farmácia Social - <mruberson@gmail.com>

Co-author(s):

• Leonardo Maurício Diniz - Diniz, L.M. - Universidade Federal de Minas Gerais, Clínica Médica - <leonardo.mauri@santamarcelina.org>
ORCID: https://orcid.org/0000-0001-9651-8485
• Jéssica Barreto Ribeiro dos Santos - Ribeiro dos Santos, Jéssica Barreto - jessica_oterrab@hotmail.com - <jessica_oterrab@hotmail.com>
• Edna Afonso Reis - Reis, E.A - Universidade Federal de Minas Gerais, Estatística - <ednareis@gmail.com>
ORCID: https://orcid.org/0000-0003-1465-9167
• Adriana Rodrigues da Mata - da Mata, Adriana Rodrigues - Universidade Federal de Minas Gerais, Farmácia Social - <adriana.mata@gmail.com>
• Vânia Eloisa de Araújo - Araújo, Vânia Eloisa de - Universidade Federal de Minas Gerais, Farmácia Social - <vaniaearaujo@gmail.com>
• Juliana Alvares - Alvares, J. - Belo Horizonte, MG - Universidade Federal de Minas Gerais, Farmácia Social - <jualvares@gmail.com>
• Francisco de Assis Acúrcio - Acúrcio, Francisco de Assis - Universidade Federal de Minas Gerais, Farmácia Social - <acurcio@medicina.ufmg.br>

Thematic Area:

Assistência Farmacêutica

Abstract:

The objective of this study was to evaluate the use of drugs and the factors associated with polypharmacy in patients with diabetes mellitus (DM) in Minas Gerais. Descriptive analysis of drugs in use and logistic regression to estimate the association between socio-demographic and clinical characteristics with polypharmacy were performed. Of the 2619 respondents, 56.5% were in polypharmacy. Drugs for DM, agent in renin-angiotensin system, and diuretics are the most frequently used. Factors such as age, comorbidities and increased access to health services were associated with polypharmacy. It was observed high prevalence of polypharmacy, which requires a suitable care and better quality of drug use in this population.

Keywords:

Diabetes mellitusDrug utilizationPolypharmacyPharmacoepidemiology

Content:

Access Issue in Scielo

Other languages: